Literature DB >> 17437748

Sinus of Valsalva aneurysms--47 years of a single center experience and systematic overview of published reports.

Sherif Moustafa1, Farouk Mookadam, Leslie Cooper, Guleid Adam, Kenton Zehr, John Stulak, David Holmes.   

Abstract

A retrospective study was undertaken to review demographic data, clinical presentation, outcomes, and long-term results of surgical repair of sinus of Valsalva aneurysms (SVAs). SVAs are a rare anomaly. Surgery is the treatment of choice. A retrospective review of an institutional database identified 86 patients who underwent SVA repair from 1956 to 2003. Follow-up ranged from 3 months to 40 years. The median age was 45 years (range 5 to 80). Approximately 44% of the patients had associated aortic regurgitation. Ruptures occurred in 34% of patients. The predominant fistula was from the right sinus of Valsalva to the right ventricle. Most (65%) were diagnosed by echocardiography, and the remaining (35%) were diagnosed on cardiac catheterization. All subjects underwent SVA repair. Seventy-two patients (84%) underwent other cardiac procedures at the time of aneurysm repair. Six patients (7%) died perioperatively, and the actuarial 10-year survival rate was 63%. In conclusion, echocardiography is the most frequently used diagnostic tool. The most common site of the aneurysm was the right coronary sinus. The concomitant surgical repair of associated ventricular septal defect, atrial septal defect, and the aortic valve is often required. Elective surgical repair can be performed with low risk.

Entities:  

Mesh:

Year:  2007        PMID: 17437748     DOI: 10.1016/j.amjcard.2006.11.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  70 in total

1.  Unruptured sinus of Valsalva aneurysm presenting with concurrent Morgagni hernia.

Authors:  Jonathan J Masor; S Scott Davis; Edward P Chen; Travis S Henry; Wendy M Book
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

2.  Coronary CT angiography with reformatting demonstrates a sinus of Valsalva aneurysm.

Authors:  Kuei-Hong Kuo; Chui-Mei Tiu
Journal:  Pediatr Radiol       Date:  2008-08-08

3.  eComment. Sinus of Valsalva aneurysm presenting with angina.

Authors:  Dimitrios V Avgerinos
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

4.  Pseudoaneurysm of the ascending aorta ruptured into the right ventricle mimicking an acute myocardial infarction.

Authors:  Toshiya Okajima; Yuichi Baba; Satoshi Takeshita
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

5.  Surgical repair of a sinus of a Valsalva aneurysm ruptured into the left ventricle.

Authors:  Masaaki Ryomoto; Masataka Mitsuno; Hiroyuki Nishi; Shinya Fukui; Yuji Miyamoto; Shuichiro Takanashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-09-24

6.  Ruptured sinus of Valsalva aneurysm from left coronary sinus into right atrium: a rare anomaly with an odd presentation.

Authors:  Ramalingam Vadivelu; Manoj Kumar Rohit; Mukesh Yadav
Journal:  BMJ Case Rep       Date:  2013-03-25

7.  [Complication of a complex heart failure: perforation of a sinus Valsalva [corrected] aneurysm].

Authors:  Ralf Felgendreher; Alessandro Cuneo; Stefan Hochreuther; Dirk Härtel; Ulrich Tebbe
Journal:  Herz       Date:  2009-05-16       Impact factor: 1.443

8.  Surgical correction of ruptured aneurysms of the sinus of Valsalva using on-pump beating-heart technique.

Authors:  Ansheng Mo; Hui Lin
Journal:  J Cardiothorac Surg       Date:  2010-05-14       Impact factor: 1.637

9.  Transcatheter device closure of ruptured sinus of Valsalva: Immediate results and short term follow up.

Authors:  Supratim Sen; Amitabha Chattopadhyay; Mily Ray; Biswajit Bandyopadhyay
Journal:  Ann Pediatr Cardiol       Date:  2009-01

10.  Unusual clinical course after surgical repair of unruptured aneurysm of sinus of Valsalva.

Authors:  Yoshimi Sato; Tatsuya Kawasaki; Michiyo Yamano; Sakiko Honda; Kuniyasu Harimoto; Shigeyuki Miki; Tadaaki Kamitani; Satoaki Matoba
Journal:  J Med Ultrason (2001)       Date:  2016-05-21       Impact factor: 1.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.